Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD

Respiratory Medicine

Volumn 108, Issue 12, 2014, Pages 1794-1800

  Jain, Vipul V ^a   Allison, Richard ^a   Beck, Sandra J ^b   Jain, Ratnali ^a   Mills, Paul K ^a   McCurley, James W ^b   Van Gundy, Karl P ^a   Peterson, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Neurosciences Critical Care Units   (United States)

Author keywords

Asthma; COPD; Disease management program; Exacerbations; Healthcare utilization; Spirometry

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHRONIC LUNG DISEASE PROGRAM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; DISEASE EXACERBATION; EMERGENCY CARE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH PROGRAM; HOSPICE CARE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; LENGTH OF STAY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; PULMONARY REHABILITATION; RESIDUAL VOLUME; SELF CARE; SINUSITIS; SMOKING; SPIROMETRY; AGED; DISEASE MANAGEMENT; ECONOMICS; EMERGENCY HEALTH SERVICE; INTEGRATED HEALTH CARE SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROGRAM EVALUATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; UTILIZATION;

ADULT; AGED; ASTHMA; CALIFORNIA; DELIVERY OF HEALTH CARE, INTEGRATED; DISEASE MANAGEMENT; EMERGENCY SERVICE, HOSPITAL; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROGRAM EVALUATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF CARE; TREATMENT OUTCOME;

EID: 84927691741     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.09.010     Document Type: Article

References (30)

1. http://www.cdc.gov/asthma/impacts-nation/asthmafactsheet.pdf, [accessed 12.06.14].
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-73.
3. Miller JD, Foster T, Boulanger L, et al. Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data. COPD 2005; 2: 311-8.
4. Prieto-Centurion V, Markos MA, Ramey NI, et al. Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. Ann Am Thorac Soc 2014; 11: 417-24.
5. Williams MV A requirement to reduce readmissions: take care of the patient, not just the disease. JAMA 2013; 309: 394-6.
6. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 890-6.
7. Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med 2012; 156: 673-83.
8. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014; 3:CD002990.
9. Andrews KL, Jones SC, Mullan J. Asthma self management in adults: a review of current literature. Collegian 2014; 21: 33-41.
10. Kenyon CC, Melvin PR, Chiang VW, et al. Rehospitalization for childhood asthma: timing, variation, and opportunities for intervention. J Pediatr 2014; 164: 300-5.
11. ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005; 26: 812-8.
12. Hasegawa K, Tsugawa Y, Tsai CL, et al. Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease. Respir Res 2014; 15: 40.
13. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-31.
14. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67: 957-63.
15. GINA. Global strategy for asthma management and prevention. 2012. http://www.ginasthma.org/local/uploads/files/GINA-Report-March13-1.pdf [accessed May 2013].
16. GOLD GIfCOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. 2011. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html [accessed May 2013].
17. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52.
18. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-67.
19. Ivanova JI, Bergman R, Birnbaum HG, et al. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol 2012; 129: 1229-35.
20. Oostenbrink JB, Rutten-van Molken MP. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med 2004; 98: 883-91.
21. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2012; 363: 1128-38.
22. Lusuardi M, Orlandini D. Underutilization of spirometry for the diagnosis of COPD. Chest 2008; 133: 313-4 [author reply 314].
23. Ali Z, Ulrik CS. Incidence and risk factors for exacerbations of asthma during pregnancy. J Asthma Allergy 2013; 6: 53-60.
24. Steppuhn H, Langen U, Scheidt-Nave C, et al. Major comorbid conditions in asthma and association with asthma-related hospitalizations and emergency department admissions in adults: results from the German national health telephone interview survey (GEDA) 2010. BMC Pulm Med 2013; 13: 46.
25. Martinez CH, Okajima Y, Murray S, et al. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res 2014; 15: 62.
26. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363: 1715-26.
27. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-54.
28. Postma DS, Reddel HK, ten Hacken NH, et al. Asthma and chronic obstructive pulmonary disease: similarities and differences. Clin Chest Med 2014; 35: 143-56.
29. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-81.
30. Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COP Deasthma. Chest 2014; 145: 297-304.